OxyContin drug-maker Purdue Pharma mulls bankruptcy due to myriad lawsuits | CBC News
OxyContin maker Purdue Pharma LP is exploring filing for
bankruptcy to address potentially significant liabilities from roughly
2,000 lawsuits alleging the drug manufacturer contributed to the deadly
opioid crisis sweeping the United States and Canada, people familiar
with the matter said on Monday.
bankruptcy to address potentially significant liabilities from roughly
2,000 lawsuits alleging the drug manufacturer contributed to the deadly
opioid crisis sweeping the United States and Canada, people familiar
with the matter said on Monday.
The potential move shows how
Purdue and its wealthy owners, the Connecticut-based Sackler family, are
under pressure to respond to mounting litigation accusing the drugmaker
of misleading doctors and patients about risks associated with
prolonged use of its prescription opioids.